Stage at which errors were detected for each product type
| Product type | Stage at which error detected | |||||||||
| First check in assembly area | Operator check in preparation area | During labelling | Final check prior to release | At release stage | In clinical area prior to administration | In clinical area during or after administration | Other | Not recorded | Total | |
| Cytotoxic adult | 1045 (55.9%) | 109 (5.8%) | 47 (2.5%) | 451 (24.1%) | 65 (3.5%) | 108 (5.8%) | 7 (0.4%) | 31 (1.7%) | 5 (0.3%) | 1868 |
| Cytotoxic paediatric | 27 (24.3%) | 11 (9.9%) | 5 (4.5%) | 41 (36.9%) | 6 (5.4%) | 16 (14.4%) | 1 (0.9%) | 4 (3.6%) | 0 | 111 |
| Parenteral nutrition—adult | 383 (56.2%) | 56 (8.2%) | 30 (4.4%) | 99 (14.5%) | 43 (6.3%) | 22 (3.2%) | 4 (0.6%) | 43 (6.3%) | 1 (0.1%) | 681 |
| Parenteral nutrition—paediatric | 74 (41.3%) | 21 (11.7%) | 0 | 47 (26.3%) | 16 (8.9%) | 7 (3.9%) | 3 (1.7%) | 11 (6.1%) | 0 | 179 |
| Other intravenous additive | 504 (39.3%) | 179 (14.0%) | 128 (10.0%) | 262 (20.5%) | 110 (8.6%) | 35 (2.7%) | 6 (0.5%) | 56 (4.4%) | 1 (0.1%) | 1281 |
| Other prefilled syringes | 60 (19.4%) | 24 (7.7%) | 4 (1.3%) | 76 (24.5%) | 78 (25.2%) | 9 (2.9%) | 1 (0.3%) | 58 (18.7%) | 0 | 310 |
| Other | 68 (31.3%) | 33 (15.2%) | 7 (3.2%) | 35 (16.1%) | 40 (18.4%) | 3 (1.4%) | 2 (0.9%) | 26 (12%) | 3 (1.4%) | 217 |
| Not recorded | 24 (54.5%) | 3 (6.8%) | 3 (6.8%) | 8 (18.2%) | 2 (4.5%) | 2 (4.5%) | 0 | 0 | 2 (4.5%) | 44 |
| Total | 2185 (46.6%) | 436 (9.3%) | 224 (4.8%) | 1019 (21.7%) | 360 (7.7%) | 202 (4.3%) | 24 (0.5%) | 229 (4.9%) | 12 (0.3%) | 4691 |